303 related articles for article (PubMed ID: 20660113)
1. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.
Hébert SS; Papadopoulou AS; Smith P; Galas MC; Planel E; Silahtaroglu AN; Sergeant N; Buée L; De Strooper B
Hum Mol Genet; 2010 Oct; 19(20):3959-69. PubMed ID: 20660113
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
3. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
7. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
8. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
9. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
10. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
[TBL] [Abstract][Full Text] [Related]
11. [Tauopathy and Alzheimer disease: a full degenerating process].
Buée L; Delacourte A
Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
[TBL] [Abstract][Full Text] [Related]
12. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
[TBL] [Abstract][Full Text] [Related]
13. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
14. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
[TBL] [Abstract][Full Text] [Related]
15. Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain.
Fujimura M; Usuki F; Sawada M; Takashima A
Neurotoxicology; 2009 Nov; 30(6):1000-7. PubMed ID: 19666049
[TBL] [Abstract][Full Text] [Related]
16. In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.
Smith P; Al Hashimi A; Girard J; Delay C; Hébert SS
J Neurochem; 2011 Jan; 116(2):240-7. PubMed ID: 21062284
[TBL] [Abstract][Full Text] [Related]
17. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
18. A miRNA signature of prion induced neurodegeneration.
Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.
Amadoro G; Ciotti MT; Costanzi M; Cestari V; Calissano P; Canu N
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2892-7. PubMed ID: 16477009
[TBL] [Abstract][Full Text] [Related]
20. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease.
Good PF; Alapat D; Hsu A; Chu C; Perl D; Wen X; Burstein DE; Kohtz DS
J Neurochem; 2004 Nov; 91(3):716-36. PubMed ID: 15485501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
